Transcriptional activation of c-myc proto-oncogene by WT1 protein (Q40529835)

21 September 2017

Transcriptional activation of c-myc proto-oncogene by WT1 protein (English)

1 reference

21 September 2017

Youqi Han

1

1 reference

21 September 2017

Serban San-Marina

series ordinal

2

1 reference

21 September 2017

Jian Liu

series ordinal

3

1 reference

21 September 2017

Mark D Minden

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

41

1 reference

21 September 2017

6933-6941

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207609

21 September 2017

0 references

cites work

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Induction of apoptosis in fibroblasts by c-myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Alternative splicing and genomic structure of the Wilms tumor gene WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

The Wilms tumor suppressor gene wt1 is required for development of the spleen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Gene targeting in kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Wilms tumor and the WT1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Cyclin E is a target of WT1 transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Expression of the Wilms' tumor gene WT1 in the murine urogenital system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

WT1 proteins: functions in growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

inferred from DOI database lookup

7 January 2021

based on heuristic

Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

inferred from DOI database lookup

7 January 2021

based on heuristic

Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207609

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1207609

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference